MCT oil and blood sugar: what the evidence actually supports
Quick answer
MCT oil supplementation has been shown in controlled trials to modestly raise blood ketone levels and may be associated with small reductions in fasting glucose and insulin when substituted for long-chain dietary fats. However, these effects are not large enough or consistent enough to qualify MCT oil as a therapeutic intervention for prediabetes or type 2 diabetes management in current clinical guidelines. Patients managing blood glucose with medication should consult a provider before making significant dietary fat changes, as even modest metabolic shifts can affect drug efficacy and dosing needs.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @drbergofficial actually say?
Berg's claim is short and confident: MCT oil lowers blood sugar, and the reason is that "the body is going to be running on ketones, not blood sugar." He frames this as useful for prediabetes, diabetes, and insulin resistance. That's a lot of therapeutic weight to put on a dietary fat supplement, and the mechanism he describes is real but incomplete to the point of being misleading.
He isn't claiming MCT oil is a drug or a cure. The framing is more like a metabolic workaround: use fat-derived ketones as fuel and you'll need less glucose. That logic has some grounding in research, but Berg presents it as cause-and-effect when the evidence is considerably more conditional than that.
Does the science back this up?
Partially, yes. MCT oil does influence blood glucose and insulin dynamics, but the effect size is modest and context-dependent. It is not a reliable standalone intervention for diabetes management.
A 2018 randomized controlled trial by Croteau et al. in the journal Alzheimer's and Dementia found MCT supplementation raised blood ketone levels meaningfully, which confirms the ketone-production mechanism Berg describes. On the glucose side, a 2021 meta-analysis by Rial et al. in Nutrients reviewed 29 trials and found MCT consumption was associated with modest reductions in fasting glucose and insulin levels compared to long-chain triglycerides, but the effects were not consistent across all studies and were often small in absolute terms.
The "running on ketones, not blood sugar" framing is an oversimplification. The body doesn't fully switch fuel sources from a tablespoon of MCT oil. Ketone levels rise, but you're not in nutritional ketosis from MCT supplementation alone. Glucose metabolism continues in parallel.
What did they get wrong (or right)?
Berg gets the mechanism directionally right but overstates how cleanly it works. The idea that MCTs produce ketones is accurate. The idea that this meaningfully "stabilizes" someone with diabetes is where the claim runs ahead of the evidence.
People with type 2 diabetes and insulin resistance can have impaired ketone metabolism too, which complicates the "run on ketones instead" logic. A 2020 paper by Cunnane et al. in Frontiers in Aging Neuroscience noted that MCT-derived ketone production can be blunted in metabolically compromised individuals.
What's missing entirely from Berg's 30-second clip is any acknowledgment that: MCT oil adds significant calories, which matters for metabolic health; the blood sugar effects seen in studies typically accompany broader dietary changes; and people on diabetes medications face real risks from unmonitored glucose changes. Recommending MCT oil to diabetics without those caveats is irresponsible, even if the core chemistry isn't wrong.
- Ketone production from MCTs: supported by evidence
- Modest glucose reduction: supported but overstated
- Sufficient to "stabilize" diabetics: not supported as a standalone claim
What should you actually know?
MCT oil is not a blood sugar medication. If you have prediabetes, diabetes, or insulin resistance, it should be thought of as a dietary component within a broader strategy, not a fix. The research suggests it may offer modest metabolic benefits when substituted for long-chain fats, particularly in the context of a lower-carbohydrate diet, but it does not replace medication, monitoring, or physician oversight.
If you're on insulin or any glucose-lowering medication, adding MCT oil without telling your provider is a bad idea. Not because MCT oil is dangerous, but because even small shifts in glucose dynamics can affect how your medication performs.
Berg's video is the kind of content that oversimplifies a real but nuanced finding into something that sounds like a prescription. It isn't one. The underlying biochemistry is real. The clinical leap he makes is not backed by current evidence at the level of confidence he implies.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For MCT oil and blood sugar: what the evidence actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
MCT oil and blood sugar: what the evidence actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
MCT oil supplementation has been shown in controlled trials to modestly raise blood ketone levels and may be associated with small reductions in fasting glucose and insulin when substituted for long-chain dietary fats.
FormBlends verdict
MCT oil supplementation has been shown in controlled trials to modestly raise blood ketone levels and may be associated with small reductions in fasting glucose and insulin when substituted for long-chain dietary fats. However, these effects are not large enough or consistent enough to qualify MCT oil as a therapeutic intervention for prediabetes or type 2 diabetes management in current clinical guidelines. Patients managing blood glucose with medication should consult a provider before making significant dietary fat changes, as even modest metabolic shifts can affect drug efficacy and dosing needs.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MCT oil supplementation has been shown in controlled trials to modestly raise blood ketone levels and may be associated with small reductions in fasting glucose and insulin when substituted for long-chain dietary fats. However, these effects are not large enough or consistent enough to qualify MCT oil as a therapeutic intervention for prediabetes or type 2 diabetes management in current clinical guidelines. Patients managing blood glucose with medication should consult a provider before making significant dietary fat changes, as even modest metabolic shifts can affect drug efficacy and dosing needs.
- A 2021 meta-analysis of 29 trials (Rial et al., Nutrients) found MCT oil produces modest fasting glucose reductions compared to long-chain fats, but results were inconsistent across studies.
- MCT supplementation raises blood ketone levels, a mechanism confirmed by Croteau et al. (2018, Alzheimer's and Dementia), but this does not mean the body stops using glucose as a fuel source.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- A 2021 meta-analysis of 29 trials (Rial et al., Nutrients) found MCT oil produces modest fasting glucose reductions compared to long-chain fats, but results were inconsistent across studies.
- MCT supplementation raises blood ketone levels, a mechanism confirmed by Croteau et al. (2018, Alzheimer's and Dementia), but this does not mean the body stops using glucose as a fuel source.
- There are no clinical trials demonstrating MCT oil alone is sufficient to stabilize blood sugar in people with diagnosed diabetes or prediabetes.
- People with impaired metabolism, including type 2 diabetes, may have reduced capacity to convert MCTs into ketones, weakening Berg's core mechanism argument.
- MCT oil is calorie-dense, roughly 100 calories per tablespoon, meaning unchecked use can add energy intake in a population where caloric balance already matters.
- If you take glucose-lowering medications, any dietary change that affects insulin sensitivity should be discussed with a provider before implementation.
- Berg's biochemistry is directionally accurate; his clinical confidence is not supported by the current evidence base.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr. Eric Berg · TikTok creator
15.4K views on this video
Benefit of MCT Oil: Lowered Blood Sugars #drericberg #mctoil #bloodsugar #ketones #health
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dr. Eric Berg, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.